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1 Both authors contributed equally to this work.Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) expressed in Saccharomyces
cerevisiae was reversibly oxidized by hydrogen peroxide and reduced by cellular reductants. Reduc-
tion of hPTEN was delayed in each of S. cerevisiae gsh1D and gsh2D mutants. Expression of c-glut-
amylcysteine synthetase Gsh1 in the gsh1D mutant rescued regeneration rate of hPTEN. Oxidized
hPTEN was reduced by glutathione in a concentration- and time-dependent manner. Glutathiony-
lated PTEN was detected. Incubation of 293T cells with BSO and knockdown expression of GCLc in
HeLa cells by siRNA resulted in the delay of reduction of oxidized PTEN. Also, in HeLa cells transfec-
ted with GCLc siRNA, stimulation with epidermal growth factor resulted in the increase of oxidized
PTEN and phosphorylation of Akt. These results suggest that the reduction of oxidized hPTEN is
mediated by glutathione.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction metabolism [4]. It was shown that exposure of cells to H2O2 re-Glutathione (GSH) is a tripeptide thiol antioxidant that directly
scavenges free radicals and is widely distributed in living organ-
isms at millimolar concentrations [1]. GSH is synthesized in two
consecutive ATP-dependent reactions that are catalyzed by c-glut-
amylcysteine synthetase (Gsh1) and GSH synthetase (Gsh2) [1].
Several signaling proteins including protein tyrosine phosphatases
(PTPs) have been shown to undergo glutathionylation. PTP1B, a
classic PTP, undergoes glutathionylation in vitro [2].
Phosphatase and tensin homolog deleted on chromosome 10
(PTEN) is a member of the PTP family. PTEN acts as a tumor sup-
pressor by inhibiting phosphoinositide 3-kinase (PI3K)-dependent
activation of AKT [3]. Hydrogen peroxide (H2O2) is produced by all
mammalian cells as a product of normal reactive oxygen specieschemical Societies. Published by E
olog deleted on chromosome
thioredoxin; Gsh1, c-glutam-
, N-ethylmaleimide; PAGE,
rmance liquid chromatogra-
ine; EGF, epidermal growthsulted in the oxidation of PTEN through the formation of a disulﬁde
bond between cysteine 124 (Cys124) residue at the active site and a
nearby Cys71 residue, suggesting that this might function to regu-
late PTEN activity [5]. Furthermore, stimulation of macrophages
with lipopolysaccharides and phorbol ester caused the fraction of
oxidized PTEN to increase from 5% to 16% [6]. More recently, the
oxidation of PTEN has been observed in neuroblastoma cells or
HEK293 cells stimulated with insulin, HeLa cells stimulated with
epidermal growth factor (EGF), and ﬁbroblasts stimulated with
PDGF [7,8]. The oxidation of PTEN by nitrosothiols or oxidized
GSH led to modiﬁcations of the PTEN thiol such as S-nitrosylation
or S-glutathionylation [9,10].
The mechanisms by which the activity of PTEN is regulated are
still unclear even though it has been shown that the reduction of
H2O2-oxidized PTEN in cells might be dependent on thioredoxin
(Trx) [5]. In addition, the formation of a glutathionylated PTEN
was identiﬁed after GSSG treatment in vitro [10]. However, it is
not clear whether the glutathionylated form of PTEN represents
an intermediate or a stable end-point of oxidation. Therefore, in
this study, we evaluated the role of GSH in the reduction of oxi-
dized hPTEN using GSH-deﬁcient yeast models and mammalian
systems.lsevier B.V. All rights reserved.
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2.1. Yeast strains, medium, and culture condition
All Saccharomyces cerevisiae strains were derived from BY4741
(MATa his3D1 leu2D0 met15D0 ura3D0). gsh1D and gsh2D mutant
strains were generated by a one-step PCR-based method using the
URA3 or KanMX4 gene as a selectable marker [11]. Revertant strains
were generated according to a procedure described previously
[12]. Rich medium (1% yeast extract, 2% peptone, 2% glucose;
YPD) and synthetic complete (0.67% yeast nitrogen base without
amino acids, 2% glucose; SC) medium lacking the appropriate ami-
no acids for selection were prepared as previously described [13].
Cells were grown to the mid-logarithmic phase at 30 C. For induc-
tion of human PTEN protein, yeast cells were grown in SC medium,
washed several times in phosphate-buffered saline, and then incu-
bated for 2 h in a medium containing galactose.
2.2. Construction of plasmids
For construction of p416GAL-hPTEN, the coding sequence of
hPTEN was ampliﬁed by PCR using pCGN-hPTEN as a template,
where the forward primer was 50-GTGGATCCATGACAGCCATCAT
CAAAGAG-30, and the reverse primer was 50-GTAAGCTTCTAGA
CTTTTGTAATTTGTGTATG-30. The obtained PCR products were cut
with BamHI and HindIII and inserted into the BamHI–HindIII site
of the p416GAL vector. For construction of the GSH1 integrating
vector, the coding region of GSH1 along with the promoter and ter-
minator sequences were ampliﬁed by PCR using S. cerevisiae geno-
mic DNA as a template, where the forward primer was 50-
TCAGTCTAGAGTAGTTGGAGCGCAATTAGC-30 and the reverse pri-
mer was 50-AGTCGAGCTCGCAACAATTGTTCTGCAAGG-30. The ob-
tained PCR products were digested with XbaI and SacI and
cloned into the XbaI–SacI site of the pIS373 disintegrator plasmid
[12].
2.3. Validation of GSH1 revertant strain
Total RNA was isolated using the RNeasy MiniKit (Qiagen).
cDNA was generated using the M-MLV Reverse Transcriptase Kit
(Mbiotech) according to the manufacturer’s instruction. Reverse
transcription PCR was performed using the forward primer 50-
CCAAACACGAGAGACTATAC-30 and the reverse primer 50-TAT-
TCTGCAATTTCAGCTCC-30. As an internal control, the ACT1 mRNA
level was also measured using the forward primer 50-TGACTGAC-
TACTTGATGAAG-30 and the reverse primer 50-ACAGAAGGATGGAA
CAAAGC-30.
2.4. Measurement of reduced GSH
Reduced GSH was measured according to a procedure described
previously [14]. The extracts of GSH were fractionated by high-per-
formance liquid chromatography (HPLC) (LC-10Ai, Shimadzu) on a
C18 column (Metachem) and eluted with 0.1% triﬂuoroacetic acid.
2.5. Immunoblotting
S. cerevisiae strains (wild-type, gsh1D, gsh2D, and GSH1 revert-
ant strains with p426GAL-PTEN) were harvested and transferred
to a 2 ml screwcap tube with 0.5 mm glass beads and NP-40 lysis
buffer (50 mM Tris–HCl [pH 7.5], 150 mM NaCl, 5 mM EDTA, 10%
[v/v] glycerol, 0.05% [v/v] NP-40, 100 lM PMSF) containing
10 mM N-ethylmaleimide (NEM). The cells were lysed using a
beadbeater and clariﬁed by centrifugation. Mammalian cells were
also lysed in NP-40 lysis buffer (20 mM Tris–HCl [pH 7.5],150 mM NaCl, 5% [v/v] glycerol, 0.1% [v/v] NP-40, 100 lM PMSF,
50 mM NaF, 1 mM Na3VO4) containing 10 mM NEM and clariﬁed
by centrifugation. The samples were analyzed by immunoblot with
antibodies to hPTEN, Akt (Cell Signaling Technology), phospho-Akt
(Cell Signaling Technology), GCLc (Santa Cruz Biotechnology), and
GSH (Virogen) as described [5].
2.6. Expression, puriﬁcation, and in vitro assay of recombinant PTEN
hPTEN cDNA was cloned into the pQE30 vector for expression of
the protein with a histidine tag at the NH2 terminus. The histidine-
tagged wild-type protein was expressed in Escherichia coli accord-
ing to standard protocols and puriﬁed using an immobilized nickel
resin (Qiagen). After incubation of the puriﬁed PTEN in a time- and
GSH concentration-dependent manner, each sample was subjected
to non-reducing SDS–PAGE followed by immunoblot with antibod-
ies to PTEN.
2.7. RNA interference
SiRNA sequences targeting GCLc (hGCLc target sequence: GAG-
UGAUCCUUUCCUACAAdTdT) were used as previously designed
[15]. HeLa cells were transfected with the siRNA (50 pmol/well)
using HilyMax reagent (Dodindo Laboratories, Kumamoto, Japan)
according to manufacturer’s instruction. Six hours later, cells were
retransfected with the siRNA (50 pmol/well). Thirty hours after
transfection, the cells were used for the experiments.
3. Results
3.1. Glutathione mediates the reduction of oxidized hPTEN in
S. cerevisiae
We have previously shown biochemically that human PTEN,
when it is oxidized by H2O2, can be more efﬁciently reduced by thi-
oredoxin than by glutathione. The budding yeast S. cerevisiae has
been widely used as a eukaryotic cell model because of well-devel-
oped genetic tools. Therefore, we wanted to conﬁrm and establish
the redox regulation of hPTEN genetically in S. cerevisiae.
We initially examined whether hPTEN was reversibly oxidized
in S. cerevisiae when exposed to H2O2 as in human cells. The
p426GAL-hPTEN plasmid was transformed into the wild-type
strains. The wild-type strains containing hPTEN were incubated
for 10 min with various concentrations of H2O2 and the cell ex-
tracts were exposed to 10 mM NEM to block free sulfhydryls. The
extracts were then subjected to immunoblot analysis with poly-
clonal antibodies to hPTEN. Exposure of S. cerevisiae to H2O2 at a
concentration of 2 mM resulted in the appearance of the higher
mobility (oxidized) form of hPTEN, and the intensity of this band
increased as the concentration of H2O2 increased (Fig. 1A) as in
HeLa cells (5). The oxidized form of hPTEN indicates inactivation
of hPTEN [4]. The activity of hPTEN in S. cerevisiae gradually re-
turned as the time of incubation after H2O2 treatment increased
due to the reducing activity of cellular reductants and complete
activity returned after 80 min (Fig. 1B) as in HeLa cells (5). When
the extracts were subjected to reducing SDS–PAGE, only the lower
mobility hPTEN band was detected (Fig. 1A and B).
Using this mobility shift assay, we examined whether thiore-
doxins and glutathione can function as a regulator of the human
PTEN redox state. First, we obtained each of gsh1D, gsh2D, trx1D,
trx2D, and trx3D mutant strains by a one-step PCR-based method
using the URA3 or KanMX4 gene as a selectable marker. These cells
were then treated with 2 mM H2O2 and hPTEN reduction was mea-
sured at the indicated times after the removal of H2O2 by catalase.
The gsh1D mutant strain was found to be sensitive to H2O2 and
Fig. 1. The redox state of hPTEN in S. cerevisiae exposed to H2O2. The p426GAL-hPTEN plasmid was transformed into wild-type cells. Cells were incubated for 10 min with the
indicated concentrations of H2O2 (A) or for the indicated times after a 10 min treatment with 2 mM H2O2 (B). Cellular protein extracts were then alkylated with 10 mM NEM
and subjected to non-reducing (left) and reducing (right) SDS–PAGE followed by immunoblot with antibodies to hPTEN. The data are representative of three separate
experiments.
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wild-type strain (Fig. 2A and B).
To determine if the delay in hPTEN reduction was affected by c-
Glu-Cys, which is an intermediate in glutathione biosynthesis, we
examined hPTEN reduction in the gsh2D mutant strain where
presumably c-Glu-Cys can be accumulated. The gsh2Dmutant also
induced a marked delay in hPTEN reduction compared with the
wild-type strain (Fig. 2A and C). Thus, reduction of hPTEN requires
glutathione itself but not an intermediate, c-Glu-Cys.
We tested the effect of thioredoxins on hPTEN reduction. How-
ever, the reduction of oxidized hPTEN was slightly delayed in S.
cerevisiae trx3D mutant and was not nearly delayed in trx1D and
trx2D mutants (unpublished data).
To further conﬁrm that the glutathione content affected the
reduction of oxidized hPTEN, we constructed a strain that comple-
mented the gsh1D mutation. Generation of GSH1 revertant strains
was carried out using the disintegrator vector system as described
previously [12]. In contrast to the gsh1D mutant, reduction of oxi-
dized hPTEN in the GSH1 revertant strains completely recovered
after 80 min, as was observed in the wild-type strain (Fig. 3A).
The mutant and revertant of the GSH1 gene were conﬁrmed by
RT-PCR, which revealed the presence of the expected product in
the wild-type and the GSH1 revertant strain, but not in the gsh1D
mutant strain (Fig. 3B), suggesting that disruption of the GSH1 gene
affected the reduction of oxidized hPTEN. In addition, we measured
the GSH content in the wild-type, gsh1D and GSH1 revertant
strains using HPLC. As shown in Fig. 3C, the GSH content in theFig. 2. Time-dependent reduction of oxidized hPTEN in wild-type, gsh1D and gsh2D S
transformed with p426GAL-hPTEN. Cells were treated with 2 mM H2O2 for 10 min and
indicated times. Cellular protein extracts were then alkylated with 10 mM NEM and subj
with antibodies to hPTEN. The data are representative of three separate experiments.gsh1D mutant strain signiﬁcantly decreased to a basal level (less
than 5.77% compared with the wild-type strain) and the GSH con-
tent in the GSH1 revertant strain was rescued. Therefore, these re-
sults suggest that GSH1 regulates the reduction of hPTEN by
controlling GSH concentration.
3.2. GSH reduces oxidized hPTEN in vitro
To determine whether GSH directly regulates redox state of
hPTEN, we examined whether GSH could reduce hPTEN in vitro.
hPTEN was puriﬁed using His-tag fusion protein expression system
and the extent of its reduction was monitored on the basis of
mobility shift in non-reducing gels. hPTEN was rapidly reduced
by treatment with 1 mM dithiothreitol (DTT) (Fig. 4A and C, far left
lane). GSH also reduced hPTEN in a time- (Fig. 4C) and concentra-
tion-dependent manner (Fig. 4A). In the processes of reduction of
oxidized PTEN by GSH, glutathionylated PTEN was also observed
by immunoblot analysis with antibodies to GSH (Fig. 4B). This re-
sult demonstrates that GSH can reduce oxidized hPTEN by glutath-
ionylation in vitro.
3.3. Inhibition of GSH biosynthesis delays the reduction of H2O2-
oxidized PTEN
To evaluate importance of GSH in the reduction of PTEN in
mammalian cells, we incubated 293T cells with buthionine sulfox-
imine (BSO) before exposure to H2O2. BSO is a potent inhibitor of. cerevisiae strains. Wild-type (top), gsh1D (middle) and gsh2D (bottom) cells were
then treated with 1 mg/ml of catalase for 5 min. Cells were then incubated for the
ected to non-reducing (left) and reducing (right) SDS–PAGE followed by immunoblot
Fig. 3. Reduction of oxidized PTEN in the GSH1 revertant strain. The GSH1 revertant strain was obtained using the disintegrator vector system. (A) Time-dependent reduction
of oxidized hPTEN in wild-type, gsh1D and GSH1 revertant strains. The cellular extracts were prepared and analyzed as described in Fig. 2. (B) Validation of GSH1 reversion by
RT-PCR. (C) Measurement of the reduced GSH concentration. Each strain was harvested and resuspended in 0.1% triﬂuoroacetic acid. The insoluble residue was removed by
centrifugation and the supernatant was analyzed by HPLC equipped with an electrochemical detector. The data are representative of three separate experiments.
Fig. 4. Redox regulation of oxidized hPTEN by GSH in vitro. Oxidized hPTEN was obtained by Ni-column puriﬁcation. Recombinant oxidized hPTEN was reduced by
incubation with 1 mM dithiothreitol for 2 h at room temperature (far left lane). Oxidized hPTEN was incubated with the indicated concentrations of GSH (A) or for the
indicated times with 7 mM GSH (C). After alkylation with 10 mM NEM, the samples were subjected to non-reducing SDS–PAGE followed by immunoblot analysis with
antibodies to hPTEN. (B) Immunochemical analysis of GSS-PTEN. After incubation with the indicated concentrations of GSH for 120 min, the samples were subjected to non-
reducing SDS–PAGE followed by immunoblot analysis with antibodies to GSH. The data are representative of three separate experiments.
Fig. 5. Concentration-dependent effects of BSO treatment on the reduction of oxidized PTEN and cellular GSH levels. (A) Oxidation of endogenous PTEN in 293T cells exposed
to H2O2. After cells were incubated with BSO at the indicated concentrations for 24 h, they were treated with 1 mMH2O2 for 10 min and then with 1 mg/ml catalase for 5 min.
Cells were then incubated for 160 min. Cellular protein extracts were alkylated with 10 mM NEM and subjected to non-reducing (top) and reducing (bottom) SDS–PAGE
followed by immunoblot with antibodies to PTEN. (B) Cells were incubated with BSO at the indicated concentrations for 24 h and GSH levels were then measured. Cells were
harvested and resuspended in 0.1% triﬂuoroacetic acid. The insoluble residue was removed by centrifugation, and the supernatant was analyzed by HPLC equipped with an
electrochemical detector. The data are representative of three separate experiments.
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cellular GSH in various different cells [15]. BSO induced a delay inthe reduction of H2O2-oxidized PTEN in a concentration-dependent
manner (Fig. 5A). BSO treatments (0.1–1000 lM) for 24 h
3554 Y. Kim et al. / FEBS Letters 584 (2010) 3550–3556decreased GSH concentrations in a dose-dependent manner, where
the reduction in GSH concentration ranged from 17% (0.1 lM) to
93% (1000 lM) relative to the control GSH concentrations (Fig. 5B).
We next examined whether the time-dependent regeneration
of H2O2-oxidized PTEN was different in cells treated with 100 lM
BSO. Treatment of cells with 100 lM BSO for 24 h induced a delayFig. 6. Effects of BSO treatment on the reduction of oxidized PTEN. After cells were incuba
for 10 min and then with 1 mg/ml catalase for 5 min. Cells were then incubated for th
subjected to non-reducing (left) and reducing (right) SDS–PAGE followed by immunoblot
Fig. 7. Effects of GCLc knockdown on the reduction of H2O2-oxidized PTEN. Thirty hours a
for GCLc in HeLa cells. Cells with (C; GCLc siRNA) or without (C; control) were treated wit
incubated for the indicated times. Cellular protein extracts were alkylated with 10 m
antibodies to PTEN. (D) The intensity of the bands corresponding to reduced PTEN in C
bands corresponding to the oxidized and reduced proteins. The data are the average ofin the reduction of H2O2-oxidized PTEN compared with control
(Fig. 6). This result suggests that the reduction of PTEN in cells is
mediated by GSH. The effect of GSH on the regeneration rate was
conﬁrmed in HeLa cells transfected with siRNAs speciﬁc for the
catalytic subunit of glutamate cysteine ligase (GCLc). The expres-
sion level of GCLc was apparently decreased in HeLa cells transfec-ted with (B) or without (A) 100 lM BSO for 24 h, cells were treated with 1 mM H2O2
e indicated times. Cellular protein extracts were alkylated with 10 mM NEM and
with antibodies to PTEN. The data are representative of three separate experiments.
fter transfection, expression of GCLc (A) and glutathione concentrations (B) by siRNA
h 1 mM H2O2 for 10 min and then with 1 mg/ml catalase for 5 min. Cells were then
M NEM and subjected to non-reducing SDS–PAGE followed by immunoblot with
was determined and presented as a percentage of the sum of the intensities of the
three separate experiments.
Fig. 8. Effects of GCLc knockdown on the amount of oxidized PTEN and phosphor-
ylation of Akt in HeLa cells stimulated with EGF. After knockdown of GCLc
expression, HeLa cells were stimulated with 100 ng/ml EGF for the indicated times,
after which cell lysates were alkylated with 10 mM NEM and subjected to non-
reducing SDS–PAGE followed by immunoblot with antibodies to PTEN (A) and
subjected to reducing SDS–PAGE followed by immunoblot with antibodies to Akt
and Akt phosphorylated on Ser-473 (pAkt) (B). (C) The intensity of the bands
corresponding to pAkt in B was determined and presented as a percentage of the
maximum stimulation of the intensities of the bands corresponding to the ratio of
pAkt to Akt. The data are the average of two separate experiments.
Fig. 9. Redox regulation of PTEN by GSH. PTEN is oxidized by H2O2 (inactive form)
and H2O2-oxidized PTEN is reversibly reduced by GSH (active form).
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by 28.65% relative to control (Fig. 7A and B). We then investigated
the effects of GSH on the reduction of oxidized PTEN. As shown in
Fig. 7C, the reduction of H2O2-oxidized PTEN was delayed com-
pared with control. Thus, the combined results of this study
strongly suggest that the reduction of PTEN is controlled by
glutathione.
3.4. Knockdown of GSH biosynthesis increases the EGF-induced
phosphorylation of Akt and PTEN oxidation
H2O2 produced in cells in response to stimulation with EGF oxi-
dizes PTEN and it contributes to enhance and sustain phosphoryla-
tion level of the serine/threonine kinase Akt that is activated via a
PI3K–dependent signaling pathway [7]. Therefore, we investigated
whether the knockdown of GSH biosynthesis by GCLc siRNA results
in an increase in oxidized PTEN and in the amount of phosphoryla-
tion of Akt in HeLa cells stimulated with EGF. The amounts of oxi-
dized PTEN (Fig. 8A) and phosphorylation of Akt were greater in
cells transfected with GCLc siRNA than in control cells at all time
points (Fig. 8B). Together, these results suggest that GSH has a
function in the redox regulation of PTEN and downstream Akt/
PKB activation.
4. Discussion
It was previously shown biochemically that oxidized PTEN was
more effectively converted back to the reduced form by thiore-
doxin than by glutathione [5]. In this study, we addressed the re-
dox regulation of hPTEN in genetic ways and surprisingly found
the importance of glutathione for regeneration of oxidized hPTEN
(Fig. 9). H2O2-oxidized PTEN was more efﬁciently reduced by glu-tathione than thioredoxins in S. cerevisiae. It might be due to the
difference of speciﬁcity between human and yeast thioredoxins.
It appears that both reduction pathways are important for regener-
ation of hPTEN in human cells while the glutathione pathway is
more important than the thioredoxin pathway in S. cerevisiae.
With these results, we performed experiments and conﬁrmed
the importance of glutathione for regeneration of oxidized hPTEN
in human cells. We monitored the extent of reduction of PTEN in
a GSH concentration-dependent manner (0–10 mM) in vitro.
Although 5 mM GSH was markedly less effective in reducing oxi-
dized PTEN, as observed previously, 10 mM GSH completely re-
duced oxidized PTEN. In the processes of reduction
glutathionylated PTEN was also detected. In addition, when we
monitored the reduction of oxidized PTEN in cells for longer time
after treatment with BSO for 24 h, the regeneration rate of oxidized
PTEN was remarkably reduced after 120 min. Knockdown expres-
sion of GCLc by siRNA interference resulted in the delay of regen-
eration of H2O2-oxidized PTEN and also in the increase of
oxidized PTEN and phosphorylation of Akt when stimulated with
EGF. However, further work is still required to identify the cysteine
residue responsible for the formation of the glutathionylated PTEN.
Although reduction of the H2O2-oxidized hPTEN in the S. cerevisiae
gsh1D mutant was delayed, reduction was completely recovered
later. Therefore, other redox regulators of PTEN have to be identi-
ﬁed and the redox mechanism of PTEN must be further studied.
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